KindlyMD Files $5 Billion Shelf Registration for Stock Sales
Kindly MD, Inc. announced on August 26 that it has filed a shelf registration statement with the Securities and Exchange Commission to sell up to $5 billion in common stock through an at-the-market equity program. The company, which trades on Nasdaq under the ticker NAKA, said proceeds will be used for general corporate purposes, including its Bitcoin treasury holdings, potential acquisitions, and capital projects. Details of the Offering Under the program, KindlyMD may issue and sell shares of common stock with a par value of $0.001. The filing allows the company to sell the shares incrementally at prevailing market prices. The at-the-market (ATM) structure gives the company flexibility to raise capital as needed without a single, fixed offering date. Such programs are often used to strengthen balance sheets or finance specific projects over time. KindlyMD said funds raised could go toward working capital, business or technology acquisitions, and investment in ongoing or future initiatives. A portion of the proceeds may also support its Bitcoin Treasury Strategy, which the company adopted after a recent merger. Bitcoin Strategy and Merger Context Earlier this month, KindlyMD completed its merger with Nakamoto Holdings Inc., forming a combined company that positions itself as both a healthcare provider and a Bitcoin treasury vehicle. As part of the merger, KindlyMD purchased 5,744 Bitcoin. Chief Executive Officer David Bailey said in a statement that the new stock program aligns with the company’s broader capital strategy following the merger. He noted the flexibility of the ATM structure in responding to market opportunities. The dual focus on healthcare operations and cryptocurrency holdings places KindlyMD among a small group of publicly traded companies blending traditional services with digital asset investments. The filing indicates the company intends to continue building on that approach as it seeks additional funding sources. Next Steps The shelf registration and prospectus supplement filed with the SEC provide the legal framework for the offering. Any actual stock sales would occur over time and depend on market conditions. The company did not specify a timeline for when shares might be sold or how quickly the $5 billion program could be used. Proceeds, according to the filing, will be directed based on corporate needs and strategic opportunities as they arise.
